COLL - CIK 0001267565
The table below shows COLLEGIUM PHARMACEUTICAL, INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $329.32M | $204.98M | $274.75M | $124.23M | $103.56M | $93.94M |
| Capital expenditure | $1.74M | $1.65M | $461.00K | $1.62M | $1.94M | $5.55M |
| Investing cash flow | -$63.53M | -$287.76M | -$70.81M | -$573.69M | -$1.94M | -$373.77M |
| Dividends paid | - | - | - | - | - |
COLLEGIUM PHARMACEUTICAL, INC reported operating cash flow of $329.32M for fiscal year 2025. That is up 60.7% from $204.98M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$75.05M (FY 2016) to $329.32M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $25.10M | $60.02M | $75.00M | $14.06M | $47.86M | - |
| Financing cash flow | -$110.25M | -$60.60M | -$140.18M | $436.72M | -$89.30M | $286.47M |